Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

The age distribution of the SARHC patients.

The distribution is semi-normal, with more patients falling in the 41–50 year-old range (n = 89; 19.9%). Twenty-six countries were represented, with Nepali-speaking Bhutanese refugees comprising the biggest cohort (n = 107, 43.1%), followed by Iraqi (n = 35, 14.1%), Burmese (n = 30, 12.1%) and Iranian (n = 19, 7.7%) refugees (Table 1).

More »

Fig 1 Expand

Table 1.

The distribution of SARHC patients by their country of origin.

More »

Table 1 Expand

Table 2.

Distribution of languages spoken by patients at the SARHC.

More »

Table 2 Expand

Fig 2.

The BMI distribution of the SARHC patients.

Underweight: BMI ≤ 18.5; Normal: 18.5 >BMI ≤24.9; Overweight: 25 ≥ BMI < 30; Obese: BMI ≥ 30.

More »

Fig 2 Expand

Fig 3.

The distribution of blood pressure (BP) readings of the SARHC patients expressed in % of total measurements.

Normal BP was a systolic blood pressure (SBP) < 120 mmHg and a diastolic blood pressure (DBP) < 80 mmHg; elevated BP was SBP 120–129 mmHg and DBP < 80 mmHg; Hypertension 1 (HTN 1) was SBP 130–139 mmHg or DBP 80–89 mmHg; Hypertension 2 (HTN 2) was SBP > 140 mmHg or DBP > 90 mmHg, and Hypertensive Crisis (HTN Crisis) was SBP > 180 mmHg or DBP > 120 mmHg.

More »

Fig 3 Expand

Table 3.

The distribution of chief complaints of the patients at the SARHC.

More »

Table 3 Expand

Table 4.

The top 10 running diagnoses at the SARHC.

More »

Table 4 Expand

Table 5.

List of running diagnoses among the 5 most represented countries.

More »

Table 5 Expand

Fig 4.

The most commonly prescribed medications at the SARHC.

PPI/H2 Blocker: proton-pump inhibitor/Histamine receptor-2 blocker; APAP: acetaminophen; NSAID: non-steroidal anti-inflammatory; H1 blocker: Histamine receptor-1 blocker.

More »

Fig 4 Expand

Table 6.

Tobacco and alcohol consumption of the SARHC patients.

More »

Table 6 Expand